News | November 07, 2024
RPG Life Sciences posts Q2 FY25 revenue Up by 12% YoY
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Specialty Chemicals grew 38% YoY for FY23
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
Subscribe To Our Newsletter & Stay Updated
